Listed by the USPTO as GODDARD, LAURA B
Tech Center 1600 • Art Units: 1618 1642 1645 1646 1647 1651 1671
This examiner grants 51% of resolved cases
This examiner works in tech center 1600 and art unit 1618, with 1285 resolved cases. The allowance rate is 50.8%, and the median time to allowance is 1182 days. The interview lift is 13.6%, indicating a modest positive association that does not materially change the overall balance of the profile.
Representative companies include Board of Regents of the University of Texas System, Aulos Bioscience Inc., and Bright Peak Therapeutics AG. The principal firms are GOODWIN PROCTER LLP, BAKER BOTTS L.L.P., and NORTON ROSE FULBRIGHT US LLP. The large record supports a stable planning signal, while the near-even allowance rate and extended timing favor careful claim management.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18409276 | METHODS AND COMPOSITIONS FOR ACTIVATION OF T CELLS USING NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON T CELLS | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18035160 | HLA CLASS II-RESTRICTED TCRS AGAINST THE KRAS G12>V ACTIVATING MUTATION | Non-Final OA | The Regents of the University of California |
| 18022593 | Modulatory Substance of Tumor Immune Microenvironment, and Preventive, Diagnostic and/or Therapeutic Utilization of the Same | Final Rejection | The University Of Tokyo |
| 17946094 | METHODS FOR DNA-DEPENDENT TARGETING OF A CELL PERMEANT ANTIBODY | Final Rejection | The United States GOVERNMENT As represented By The Department of Veterans Affairs |
| 18496065 | THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS FOR CANCER | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 18553042 | VACCINE COMPOSITION AGAINST CORONAVIRUS | Final Rejection | LG CHEM, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy50.8% of resolved applications examined by Laura B Goddard were allowed (1,285 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +13.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Laura B Goddard took 1,182 days on average from filing to allowance.
Laura B Goddard examines applications in Art Unit 1618 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
